Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |

Bioretec's Hybrid Composite Patent Has Been Approved in Europe September 12 2022

2022 Lucintel Composites Market Insights, September 12, 2022

The European Patent Office has informed that it has approved Bioretec Oy's hybrid composite material patent application EP3782657A1 and will grant and publish the patent after the Company's confirmation.
Approved patent concerns magnesium-based reinforced composite material, i.e., hybrid composite. The patent also includes the usage of the hybrid composite material in the manufacturing of a medical device or a part of such a device.
The patented hybrid composite material will be used in those products of Bioretec's RemeOs product family that require very high load-bearing capacity. Targeted applications include intramedullary nails in the long bones of the upper and lower extremities and implants for spinal fusion.
The patent application process for the hybrid composite material in regions outside of Europe continues based on the international PCT patent application WO2021032882A1, and the Company will inform about patent approvals in other regions as the application process progress.

For identifying growth opportunities in Composites Market: Trends, Opportunities and Competitive Analysis, please visit https://www.lucintel.com/composites-market.aspx